SCHEMBL3937302

SCHEMBL3937302

CCO[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)C5CC5[C@@]4(C)[C@@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR3C2 P08235 7/20 0.47
▸ PGR P06401 6/20 0.47
▸ AR P10275 2/20 0.47
▸ CHRM1 P11229 2/20 0.47
▸ NR3C1 P04150 4/20 0.46
▸ ABCC3 O15438 1/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ ABCB11 O95342 1/20 0.46
▸ HIF1A Q16665 7/20 0.46
▸ LMNA P02545 3/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ USP2 O75604 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ SERPINA6 P08185 1/20 0.43
▸ CYP2C19 P33261 2/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3940208 0.86 NR3C1 (0.48) NR3C2PGRARCHRM1NR3C1
SCHEMBL3931094 0.84 HIF1A (0.64) NR3C2PGRARCHRM1NR3C1
SCHEMBL3938527 0.80 HIF1A (0.71) NR3C2PGRARCHRM1NR3C1
SCHEMBL3938530 0.80 HIF1A (0.71) NR3C2PGRARCHRM1NR3C1
SCHEMBL3930867 0.79 PGR (0.44) NR3C2PGRARCHRM1NR3C1
SCHEMBL10707185 0.78 NR3C1 (0.46) NR3C2PGRARCHRM1NR3C1
SCHEMBL10703308 0.76 AR (0.54) NR3C2PGRARCHRM1NR3C1
SCHEMBL11799696 0.75 CYP3A4 (0.60) NR3C2PGRARCHRM1NR3C1
SCHEMBL10705465 0.75 CYP3A4 (0.60) NR3C2PGRARCHRM1NR3C1
SCHEMBL10707423 0.74 NR3C1 (0.59) NR3C2PGRARCHRM1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976997-B1 PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA,10ALPHA-STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS SOLVAY PHARM GMBH (DE) 2009-04-08 — — EP claimed
US-20070212751-A1 Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods SOLVAY PHARMACEUTICALS GMBH (DE) 2007-09-13 — — US claimed
EP-1976997-B1 PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA,10ALPHA-STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS SOLVAY PHARM GMBH (DE) 2009-04-08 — — EP disclosed
US-20070212751-A1 Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods SOLVAY PHARMACEUTICALS GMBH (DE) 2007-09-13 — — US disclosed
Send feedback